Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Eros Int'l. Files For IPO Of Up To $250 Mln - Quick Facts

Eros International Plc (EROS.L) filed for an initial public offering of its stock Friday with the U.S. Securities and Exchange Commission, with the proposed maximum offering price of $250 million. The company intends plans to list on the New York Stock Exchange under the ticker, "EROS."

Also, the company plans to use the net proceeds from this offering to fund new co-productions and acquisitions, including catalog content, to grow our digital and other distribution channels and for general corporate purposes. The offering is being made through Deutsche Bank Securities, BofA Merrill Lynch, Citigroup, and UBS Investment Bank.

Click here to receive FREE breaking news email alerts for Eros International and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
European stocks are seen opening lower on Monday, tracking weak commodity prices and a subdued trend across the Asia-Pacific region as investors look ahead to Chinese manufacturing data due on Tuesday for important clues about China's growth outlook. China is experiencing stable growth and there... Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.